AKT1 and endometrial cancer: It was reported that the PI3K-Akt signaling pathway promotes progestin resistance in endometrial cancer [8, 34], which is consistent with our KEGG enrichment analysis (showed in Fig. 1A) and our experimental results (showed in Supplementary Fig. 4A, Original Data Supplementary Fig. 4A).